Last updated on April 2018

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma


Brief description of study

This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.

Detailed Study Description

The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell Lymphomas (CTCL). The primary objective is to determine the overall response rate of doxycycline monotherapy in patients with relapsed CTCL.

Clinical Study Identifier: NCT02341209

Contact Investigators or Research Sites near you

Start Over

Carolina V. Alexander-Savino, B.S.,CCRC

Rochester General Hospital
Rochester, NY United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.